Literature DB >> 11497369

Limb lengthening in short stature patients.

R Aldegheri1, C Dall'Oca.   

Abstract

A series of 140 patients with short stature operated on for limb lengthening (80 had achondroplasia, 20 had hypochondroplasia, 20 had Turner syndrome, 10 had idiopathic short stature due to an undemonstrated cause, 5 regarded their stature as too short, and 5 had a psychopathic personality due to dysmorphophobia that had developed because of their short stature) was reviewed. All patients underwent symmetric lengthening of both femora and tibiae; 10 of these achondroplastic patients underwent lengthening of the humeri. We carried out the 580 lengthening procedures by means of three different surgical techniques: 440 callotasis, 120 chondrodiatasis and 20 mid-shaft osteotomy. In the 130 patients with a disproportionate short stature, the average gain in length was 18.2 +/- 3.93 cm: 43.8% had complications and 3.8% had sequelae; the average treatment time was 31 months. In the 10 patients with proportionate short stature, the average gain in length was 10.8 +/- 1.00 cm: 4 experienced complications and none had sequelae; the average treatment time was 21 months. Patients who underwent lengthening of the upper limbs experienced an average gain in length of 10.2 +/- 1.25 cm: the average treatment time was 9 months and none of them experienced any complications or sequelae. The authors discuss how difficult it is to achieve the benefits of this surgery: they underline the strong commitment on the part of the patients and their families, the time in the hospital, the number of operations and, above all, the severity of those permanent sequelae that occurred.

Entities:  

Mesh:

Year:  2001        PMID: 11497369

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  22 in total

1.  Bilateral double level tibial lengthening in dwarfism.

Authors:  Rolf D Burghardt; Koichi Yoshino; Naoya Kashiwagi; Shigeo Yoshino; Anil Bhave; Dror Paley; John E Herzenberg
Journal:  J Orthop       Date:  2015-06-03

Review 2.  FGFR3-related dwarfism and cell signaling.

Authors:  Daisuke Harada; Yoshitaka Yamanaka; Koso Ueda; Hiroyuki Tanaka; Yoshiki Seino
Journal:  J Bone Miner Metab       Date:  2008-12-09       Impact factor: 2.626

3.  Editorial: indications--on the fringes and in the mainstream.

Authors:  Seth S Leopold; Sanjeev Sabharwal
Journal:  Clin Orthop Relat Res       Date:  2014-09-11       Impact factor: 4.176

4.  Achondroplasia and limb lengthening: Results in a UK cohort and review of the literature.

Authors:  James Donaldson; Syed Aftab; Christopher Bradish
Journal:  J Orthop       Date:  2015-01-28

5.  Cosmetic lower limb lengthening by Ilizarov apparatus: what are the risks?

Authors:  Konstantin I Novikov; Koushik N Subramanyam; Serghei O Muradisinov; Olga S Novikova; Elina S Kolesnikova
Journal:  Clin Orthop Relat Res       Date:  2014-09-03       Impact factor: 4.176

6.  Achondroplasia: Craniofacial manifestations and considerations in dental management.

Authors:  Afnan Al-Saleem; Asma Al-Jobair
Journal:  Saudi Dent J       Date:  2010-07-14

7.  A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.

Authors:  Min Jin; Ying Yu; Huabing Qi; Yangli Xie; Nan Su; Xiaofeng Wang; Qiaoyan Tan; Fengtao Luo; Ying Zhu; Quan Wang; Xiaolan Du; Cory J Xian; Peng Liu; Haiyang Huang; Yue Shen; Chu-Xia Deng; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2012-09-26       Impact factor: 6.150

8.  Humerus varus in a patient with pseudohypoparathyroidism.

Authors:  Tae Joon Cho; In Ho Choi; Chin Youb Chung; Won Joon Yoo; Sei Won Yang
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

9.  Does humeral lengthening with a monolateral frame improve function?

Authors:  Abhijit Y Pawar; Thomas H McCoy; Austin T Fragomen; S Robert Rozbruch
Journal:  Clin Orthop Relat Res       Date:  2012-08-28       Impact factor: 4.176

10.  [Quality of life in children, adolescents, and young adults with achondroplasia].

Authors:  A C Rohenkohl; M Bullinger; J Quitmann
Journal:  Orthopade       Date:  2015-03       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.